Independent Order of Foresters Cuts Stake in Aetna Inc. (NYSE:AET)
Independent Order of Foresters cut its position in Aetna Inc. (NYSE:AET) by 5.2% during the second quarter, Holdings Channel reports. The firm owned 915 shares of the company’s stock after selling 50 shares during the period. Independent Order of Foresters’ holdings in Aetna were worth $139,000 at the end of the most recent quarter.
Several other institutional investors have also recently added to or reduced their stakes in AET. BlackRock Inc. increased its position in Aetna by 3,374.9% in the first quarter. BlackRock Inc. now owns 30,712,219 shares of the company’s stock worth $3,917,344,000 after buying an additional 29,828,390 shares during the period. Vanguard Group Inc. increased its position in Aetna by 3.8% in the first quarter. Vanguard Group Inc. now owns 23,117,526 shares of the company’s stock worth $2,948,640,000 after buying an additional 838,578 shares during the period. FMR LLC increased its position in Aetna by 2.2% in the first quarter. FMR LLC now owns 7,903,233 shares of the company’s stock worth $1,008,059,000 after buying an additional 167,261 shares during the period. Bank of New York Mellon Corp increased its position in Aetna by 3.9% in the first quarter. Bank of New York Mellon Corp now owns 4,378,982 shares of the company’s stock worth $558,540,000 after buying an additional 165,278 shares during the period. Finally, Dimensional Fund Advisors LP increased its position in Aetna by 0.6% in the first quarter. Dimensional Fund Advisors LP now owns 3,962,514 shares of the company’s stock worth $505,399,000 after buying an additional 21,953 shares during the period. Hedge funds and other institutional investors own 91.73% of the company’s stock.
Aetna Inc. (AET) opened at 152.42 on Friday. The stock has a market cap of $50.62 billion, a price-to-earnings ratio of 33.83 and a beta of 0.54. Aetna Inc. has a 12 month low of $104.59 and a 12 month high of $161.69. The stock’s 50 day moving average price is $154.28 and its 200-day moving average price is $138.79.
Aetna (NYSE:AET) last issued its quarterly earnings data on Thursday, August 3rd. The company reported $3.42 earnings per share for the quarter, topping analysts’ consensus estimates of $2.34 by $1.08. The business had revenue of $15.52 billion during the quarter, compared to the consensus estimate of $15.34 billion. Aetna had a net margin of 2.52% and a return on equity of 20.52%. The company’s revenue was down 2.7% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $2.21 earnings per share. Equities analysts expect that Aetna Inc. will post $9.46 EPS for the current year.
The company also recently disclosed a quarterly dividend, which was paid on Friday, July 28th. Shareholders of record on Thursday, July 13th were given a $0.50 dividend. The ex-dividend date was Tuesday, July 11th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.31%. Aetna’s dividend payout ratio (DPR) is currently 43.67%.
AET has been the topic of a number of recent research reports. Stifel Nicolaus reaffirmed a “buy” rating and issued a $150.00 target price (up from $130.00) on shares of Aetna in a report on Wednesday, May 3rd. Royal Bank Of Canada raised their target price on Aetna from $147.00 to $162.00 and gave the stock an “outperform” rating in a report on Friday, June 9th. BidaskClub cut Aetna from a “buy” rating to a “hold” rating in a report on Monday, July 31st. Deutsche Bank AG raised their target price on Aetna from $157.00 to $163.00 and gave the stock a “hold” rating in a report on Monday. Finally, UBS AG reaffirmed a “buy” rating and issued a $160.00 target price (up from $147.00) on shares of Aetna in a report on Wednesday, May 17th. Eight research analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the stock. The company currently has a consensus rating of “Buy” and a consensus price target of $157.09.
In related news, EVP Margaret M. Mccarthy sold 27,028 shares of the company’s stock in a transaction dated Wednesday, June 7th. The shares were sold at an average price of $149.23, for a total transaction of $4,033,388.44. Following the completion of the transaction, the executive vice president now owns 33,563 shares in the company, valued at approximately $5,008,606.49. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Chairman Mark T. Bertolini sold 103,547 shares of the company’s stock in a transaction dated Wednesday, May 17th. The stock was sold at an average price of $140.79, for a total transaction of $14,578,382.13. Following the transaction, the chairman now owns 659,888 shares of the company’s stock, valued at approximately $92,905,631.52. The disclosure for this sale can be found here. Corporate insiders own 0.90% of the company’s stock.
Aetna Company Profile
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc. (NYSE:AET).
Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.